Literature DB >> 32385014

Breast Cancer Diagnosed by MRI Using Mesoporous TiO₂-Coated (Fe₃O₄) Nanoparticles.

Bo Zheng1, Minghua Xue2, Xinyi Zhang1, Ning Tian1, Dongmei Wang1.   

Abstract

Objective: This study aimed to determine the effects of dimer captosuccinic acid-coated Fe₃O₄ (super paramagnetic) nanoparticles (NP) on 2-deoxy-d-glucose in targeted cancer cells with high rates of glucose metabolism.
Methods: We prepared Fe₃O₄@DMSA NP and 2-DG-conjugated Fe₃O₄@DMSA NP, γ-FE, O, and @DMSA-DG NP. Glucose consumption in MDA-MB-231 and MCF-7 breast cancer cells was determined using γ-Fe2O3@DMSA NP or Fe₃O₄@DMSA-DG NP, and absorption was tested using Prussian blue staining, ultraviolet colorimetry, and magnetic resonance imaging.
Results: Glucose consumption was the highest in MDA-MB-231, and the lowest in human mammary epithelial cells (HMEPiC). The significant uptake of Fe2O3@DMSA-DG NP by MDA-MB-231 and MCF-7 cells within two hours was inhibited by glucose. The uptake of Fe₃O₄@DMSA-DG NP was significantly higher in MDA-MB-231 than in MCF-7 cells, whereas Fe₃O₄@DMSA NP was not obviously uptaken by either cell line. Absorption was also not evident in HMEPiC incubated with Fe₃O₄@DMSA-DG NP and Fe₃O₄@DMSA NP. Conclusions: The tumor targeting efficacy of 2-DG coated Fe₃O₄@DMSA NP was improved over Fe₃O₄,@DMSA NP in cancer cells with high rates of glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32385014     DOI: 10.1166/jnn.2020.18437

Source DB:  PubMed          Journal:  J Nanosci Nanotechnol        ISSN: 1533-4880


  2 in total

1.  The potential application of gold-apoferritin nanocages conjugated with 2-amino-2-deoxy-glucose for imaging of breast cancer cells.

Authors:  Tuğba Nur Aslan; Elif Aşık; N Tülin Güray; Mürvet Volkan
Journal:  J Biol Inorg Chem       Date:  2020-10-31       Impact factor: 3.358

2.  Dynamic Enhanced Magnetic Resonance Imaging versus Ultrasonic Diffused Optical Tomography in Early Diagnosis of Breast Cancer.

Authors:  Feng Xue; Jie Jiang
Journal:  J Healthc Eng       Date:  2022-04-12       Impact factor: 3.822

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.